These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3533734)

  • 21. High-dose systemic streptokinase and acylated streptokinase-plasminogen complex (BRL 26921) in acute myocardial infarction: alterations of the fibrinolytic system and clearance of fibrinolytic activity.
    Köhler M; Hellstern P; Doenecke P; Schwerdt H; Ozbek C; Miyashita C; Winter R; von Blohn G; Bette L; Wenzel E
    Haemostasis; 1987; 17(1-2):32-9. PubMed ID: 3297942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction.
    Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U
    Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199
    [No Abstract]   [Full Text] [Related]  

  • 24. Anistreplase (APSAC): a clinical investigator's update. A symposium. Bermuda, August 1989. Proceedings.
    Clin Cardiol; 1990 Mar; Suppl 5():V1-72. PubMed ID: 2182233
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.
    Francis CW; Connaghan DG; Marder VJ
    Circulation; 1986 Nov; 74(5):1027-36. PubMed ID: 3533310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis.
    de Prost D; Guerot C; Laffay N; Horellou MH; Samama M
    Thromb Haemost; 1983 Dec; 50(4):792-6. PubMed ID: 6665760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversies in thrombolysis--choice of the agent.
    Horak AR; Commerford PJ
    S Afr Med J; 1990 Jan; 77(2):60-1. PubMed ID: 2104993
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolysis in coronary occlusion--the full circle.
    Bauer GE
    Aust N Z J Med; 1989 Apr; 19(2):85-7. PubMed ID: 2504138
    [No Abstract]   [Full Text] [Related]  

  • 29. Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction.
    Walker ID; Davidson JF; Rae AP; Hutton I; Lawrie TD
    Thromb Haemost; 1984 Apr; 51(2):204-6. PubMed ID: 6377564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anistreplase: a new thrombolytic for the treatment of acute myocardial infarction.
    Munger MA; Forrence EA
    Clin Pharm; 1990 Jul; 9(7):530-40. PubMed ID: 2198125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A symposium: Early intervention in the treatment of acute myocardial infarction--clinical profile of Eminase (APSAC). November 12, 1988, Washington, D.C.
    Am J Cardiol; 1989 Jul; 64(2):1A-42A. PubMed ID: 2662736
    [No Abstract]   [Full Text] [Related]  

  • 32. Study finds similar reperfusion rates with intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
    Clin Pharm; 1988 Sep; 7(9):634, 638. PubMed ID: 3071445
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombolysis, streptokinase, and TPA in the treatment of acute myocardial infarction.
    Mock MB; Chesebro JH
    Cardiovasc Clin; 1987; 18(1):247-57. PubMed ID: 2955892
    [No Abstract]   [Full Text] [Related]  

  • 34. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 35. Safe use of thrombolysis in the elderly.
    Wittry MD; Thornton TA; Chaitman BR
    Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic effects of BRL 26921 during thrombolytic treatment of acute myocardial infarction.
    Hoffmann JJ; Van Rey FJ; Bonnier JJ
    Thromb Res; 1985 Mar; 37(5):567-72. PubMed ID: 3920779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary thrombolysis: practical considerations.
    Eisenberg PR; Jaffe AS
    Cardiol Clin; 1987 Feb; 5(1):129-41. PubMed ID: 3103918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction.
    Kasper W; Erbel R; Meinertz T; Drexler M; Rückel A; Pop T; Prellwitz W; Meyer J
    J Am Coll Cardiol; 1984 Aug; 4(2):357-63. PubMed ID: 6429226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
    Sherry S
    Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
    [No Abstract]   [Full Text] [Related]  

  • 40. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.